好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Females Have Worse In-hospital Outcomes After Reperfusion Therapy in Ischemic Stroke
Cerebrovascular Disease and Interventional Neurology
P3 - Poster Session 3 (5:30 PM-6:30 PM)
3-046

The objective of this study was to determine the effect of gender on in-hospital outcomes in ischemic stroke patients undergoing reperfusion therapy.

Epidemiological studies have reported gender variability in post stroke outcomes, but there is limited data on gender effect on in-hospital outcomes, especially after acute stroke reperfusion therapy.

Acute ischemic stroke patients who underwent reperfusion therapy (intravenous thrombolysis (IVT) or mechanical thrombectomy) at an academic stroke center during 2016 - 2017 were included. Primary outcome measure was improvement in National Institute of Health Stroke Scale (NIHSS) from baseline to 24-hours. Demographic data, stroke characteristics and blood pressure over 24-hours post stroke treatment were collected.

Of 140 patients included in our study, 85 (60.71%) were males and 55 were females with a mean age of 68.8 years. 117 received IVT and 84 received mechanical thrombectomy. Median NIHSS scores at baseline and at 24-hours post reperfusion therapy were 15 and 9 respectively. Mean improvement on NIHSS scores at 24-hours was 4.9 points in males and 2.3 in females (p=0.05). After univariate analysis of predictors of NIHSS improvement, Multivariate regression analysis of candidate variables was performed adjusting for baseline NIHSS and mimimum 24-hour systolic blood pressure that showed male gender to be associated with a 3 point greater improvement in 24-hour NIHSS compared to females (p=0.02).

In our study, female gender showed worse In-hospital outcomes compared to males in patients undergoing reperfusion therapy.

Authors/Disclosures
Dinesh V. Jillella, MD (Emory University School of Medicine / Grady Memorial Hospital)
PRESENTER
Dr. Jillella has nothing to disclose.
No disclosure on file
Ken Uchino, MD (Cleveland Clinic Foundation) Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Yoram Roman Casul, MD Dr. Roman Casul has nothing to disclose.
Asad Ikram, MD, MBBS Dr. Ikram has nothing to disclose.
Christopher Calder, MD, PhD, FAAN (Presbyterian Medical Group) No disclosure on file
No disclosure on file